Generating Bone Marrow Chimeric Mouse Using GPR120 Deficient Mouse for the Study of DHA Inhibitory Effect on Osteoclast Formation and Bone Resorption.
DHA
GPR120
TNF-α
chimeric mouse
osteoclastogenesis
Journal
International journal of molecular sciences
ISSN: 1422-0067
Titre abrégé: Int J Mol Sci
Pays: Switzerland
ID NLM: 101092791
Informations de publication
Date de publication:
30 Nov 2023
30 Nov 2023
Historique:
received:
20
09
2023
revised:
22
11
2023
accepted:
29
11
2023
medline:
9
12
2023
pubmed:
9
12
2023
entrez:
9
12
2023
Statut:
epublish
Résumé
Docosahexaenoic acid (DHA) is an omega-3 fatty acid that exerts physiological effects via G protein-coupled receptor 120 (GPR120). In our previous studies, we figured out the inhibitory effects of DHA on TNF-α (Tumor necrosis factor-α)-induced osteoclastogenesis via GPR120 in vivo. Moreover, DHA directly suppressed RANKL expression in osteoblasts via GPR120 in vitro. In this study, we generated bone marrow chimeric mice using GPR120 deficient mice (GPR120-KO) to study the inhibitory effects of DHA on bone resorption and osteoclast formation. Bone marrow cells of wild-type (WT) or GPR120-KO mice were transplanted into irradiated recipient mice, which were WT or GPR120 deficient mice. The resulting chimeric mice contained stromal cells from the recipient and bone marrow cells, including osteoclast precursors, from the donor. These chimeric mice were used to perform a series of histological and microfocus computed tomography (micro-CT) analyses after TNF-α injection for induction of osteoclast formation with or without DHA. Osteoclast number and bone resorption were found to be significantly increased in chimeric mice, which did not express GPR120 in stromal cells, compared to chimeric mice, which expressed GPR120 in stromal cells. DHA was also found to suppress specific signaling pathways. We summarized that DHA suppressed TNF-α-induced stromal-dependent osteoclast formation and bone resorption via GPR120.
Identifiants
pubmed: 38069322
pii: ijms242317000
doi: 10.3390/ijms242317000
pmc: PMC10707107
pii:
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Subventions
Organisme : Japan Society for the Promotion of Science
ID : 19K10397
Organisme : Japan Society for the Promotion of Science
ID : 22K10236
Organisme : Japan Science and Technology Agency
ID : JPMJFS2102
Références
Front Immunol. 2019 Dec 13;10:2925
pubmed: 31921183
Nature. 2012 Feb 19;483(7389):350-4
pubmed: 22343897
Int J Mol Sci. 2020 Aug 25;21(17):
pubmed: 32854340
Acta Pharmacol Sin. 2008 Nov;29(11):1275-88
pubmed: 18954521
J Immunol. 2004 Oct 15;173(8):4838-46
pubmed: 15470024
Redox Biol. 2023 Jul;63:102730
pubmed: 37150150
Proc Natl Acad Sci U S A. 1998 Mar 31;95(7):3597-602
pubmed: 9520411
Arch Biochem Biophys. 2014 Nov 1;561:3-12
pubmed: 24832390
Int J Mol Sci. 2020 Feb 08;21(3):
pubmed: 32046264
Endocr Rev. 1999 Jun;20(3):345-57
pubmed: 10368775
Int J Mol Sci. 2019 May 23;20(10):
pubmed: 31126015
Int J Mol Sci. 2021 Jun 22;22(13):
pubmed: 34206294
Eur J Pharmacol. 2016 Aug 15;785:36-43
pubmed: 25987421
Prostate Cancer Prostatic Dis. 2022 Sep;25(3):539-546
pubmed: 35075215
Semin Immunol. 2014 Jun;26(3):237-45
pubmed: 24647229
Pharmacol Ther. 2023 Jul;247:108440
pubmed: 37201739
Sci Rep. 2023 Jun 6;13(1):9179
pubmed: 37280266
J Bone Miner Res. 1993 Feb;8(2):147-55
pubmed: 8442433
Biochim Biophys Acta. 2007 Apr;1768(4):994-1005
pubmed: 17081496
Prog Lipid Res. 2010 Apr;49(2):97-107
pubmed: 19815028
Prostaglandins Other Lipid Mediat. 2023 Aug;167:106733
pubmed: 37028469
Acta Reumatol Port. 2007 Apr-Jun;32(2):103-10
pubmed: 17572649
J Clin Invest. 2005 Dec;115(12):3418-27
pubmed: 16294221
Immunol Rev. 2009 Sep;231(1):241-56
pubmed: 19754901
Proc Natl Acad Sci U S A. 2023 May 9;120(19):e2218019120
pubmed: 37141171
Nature. 1999 Nov 18;402(6759):304-9
pubmed: 10580503
Neuropsychiatr Dis Treat. 2023 Apr 07;19:785-800
pubmed: 37056916
Eur J Pharmacol. 2016 Aug 15;785:10-17
pubmed: 26022530
Sci Rep. 2021 May 14;11(1):10364
pubmed: 33990655
Pharmacology. 2022;107(5-6):330-338
pubmed: 35189618
Int J Mol Sci. 2020 Jan 05;21(1):
pubmed: 31948061
J Clin Invest. 1994 Dec;94(6):2397-406
pubmed: 7989596
J Alzheimers Dis. 2023;94(3):977-991
pubmed: 37355890
BMC Immunol. 2021 Mar 25;22(1):23
pubmed: 33765924
Pharmacol Res. 2018 Jun;132:90-98
pubmed: 29665425
Comp Biochem Physiol C Toxicol Pharmacol. 2023 Jun;268:109603
pubmed: 36906246
Oral Dis. 2011 Mar;17(2):129-42
pubmed: 20659257
Immunol Rev. 2005 Dec;208:88-105
pubmed: 16313343
Life Sci. 2023 Aug 15;327:121826
pubmed: 37270172
Arch Biochem Biophys. 2008 May 15;473(2):201-9
pubmed: 18406338
Mol Nutr Food Res. 2023 Jun;67(11):e2200727
pubmed: 37029593
Atherosclerosis. 2021 Jan;316:90-98
pubmed: 33303222
Front Endocrinol (Lausanne). 2019 Mar 15;10:157
pubmed: 30949128
Foods. 2023 Apr 26;12(9):
pubmed: 37174337
Cell. 2010 Sep 3;142(5):687-98
pubmed: 20813258
Biomed Res Int. 2015;2015:421746
pubmed: 26247020
J Int Soc Sports Nutr. 2023 Dec;20(1):2174704
pubmed: 36822153
J Bone Miner Metab. 2021 Jan;39(1):19-26
pubmed: 33079279
Front Immunol. 2023 Jan 18;13:929690
pubmed: 36741381